Skip to main content
Clinical Trials/NL-OMON41555
NL-OMON41555
Completed
Not Applicable

Functional magnetic resonance imaging of pancreatic cancer: a feasibility and reproducibility study - MRI of pancreatic cancer

Academisch Medisch Centrum0 sites30 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
pancreatic cancer
Sponsor
Academisch Medisch Centrum
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \* Patients with pancreatic tumors, with histological or cytological proof of adenocarcinoma or a high suspicion on CT imaging.
  • \* Any tumor with a size \* 1cm
  • \* WHO\-performance score 0\-2
  • \* Written informed consent

Exclusion Criteria

  • \* Any psychological, familial, sociological or geographical condition potentially hampering adequate informed consent or compliance with the study protocol.
  • \* Contra\-indications for MR scanning, including patients with a pacemaker, cochlear implant or neurostimulator; patients with non\-MR compatible metallic implants in their eye, spine, thorax or abdomen; or an aneurysm clip in their brain; patients with severe claustrophobia.
  • \* Renal failure (GFR \< 60 ml/min) hampering safe administration of a double bolus of Gadolinium containing MR contrast agent.
  • \* For the reproducibility part of the protocol: surgery, radiation and/or chemotherapy foreseen within the timeframe needed for MRI scanning.

Outcomes

Primary Outcomes

Not specified

Similar Trials